PROP’s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences
Pallimed
MAY 3, 2021
Ultimately, PROP identified a more accommodating regulatory agency than the FDA, the Centers for Disease Control and Prevention (CDC), which revealed via engagement webinars on September 16 and 17, 2015, that it had been drafting its own Opioid Prescribing Guidelines (21).
98 
Let's personalize your content